1. Home/
  2. Compounds/
  3. erlotinib:PLX-4032 (2:1 mol/mol)

erlotinib:PLX-4032 (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2erlotinib:PLX-4032 (2:1 mol/mol)
PharmacoGx erlotinib:PLX-4032 (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to erlotinib:PLX-4032 (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TBC1D17 CTRPv2 pan-cancer AAC -0.089 0.02
mRNA TMEM238 CTRPv2 pan-cancer AAC 0.1 0.02
mRNA FERMT2 CTRPv2 pan-cancer AAC -0.1 0.02
mRNA UBE2D2 CTRPv2 pan-cancer AAC -0.09 0.02
mRNA CDK10 CTRPv2 pan-cancer AAC -0.09 0.02
mRNA RP11-385D13.1 CTRPv2 pan-cancer AAC 0.098 0.02
mRNA BFSP1 CTRPv2 pan-cancer AAC 0.091 0.02
mRNA BEND3 CTRPv2 pan-cancer AAC -0.096 0.02
mRNA TMTC1 CTRPv2 pan-cancer AAC -0.091 0.02
mRNA FAM219A CTRPv2 pan-cancer AAC -0.097 0.02
Download CSV